Guaiac based faecal occult blood testing for colorectal cancer screening: An obsolete strategy?

Gut

Volumn 61, Issue 7, 2012, Pages 959-960

  Young, Graeme P ^a   Fraser, Callum G ^b   Halloran, Stephen P ^c   Cole, Steven ^d  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLONOSCOPY; COLORECTAL CANCER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FECAL IMMUNOHISTOCHEMISTRY TEST; FECES ANALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; NOTE; OCCULT BLOOD TEST; PRIORITY JOURNAL; RISK REDUCTION; SCREENING TEST;

ADENOMA; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; OCCULT BLOOD;

EID: 84861578597     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301810     Document Type: Note

References (17)

1. Scholefield JH, Moss SM, Mangham CM, et al. Nottingham trial of faecal occult blood testing for colorectal cancerd20 year follow up. Gut 2012;61:1036-40.
2. Mandel JS, Bond JH, Church TR, et al; Minnesota Colon Cancer Control Study. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
3. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet 1996;348:1467-71.
4. Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004;126:1674-80.
5. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008;95:1029-36.
6. Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Costeffectiveness of colorectal cancer screening. Epidemiol Rev 2011;33:88-100.
7. Benson VS, Atkin WS, Green J, et al. Towards standardizing and reporting colorectal cancer screening indicators on an international level: the International Colorectal Cancer Screening Network (ICRCSN). Int J Cancer 2012;130:2961-73.
8. Cole SR, Young GP, Esterman A, et al. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-22.
9. Cole SR, Smith A, Wilson C, et al. An advance notification letter increases participation in colorectal cancer screening. J Med Screen 2007;14:73-5.
10. Libby G, Bray J, Champion J, et al. Pre-notification increases uptake of colorectal cancer screening in all demographic groups: a randomized controlled trial. J Med Screen 2011;18:24-9.
11. Smith A, Young GP, Cole SR, et al. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006;107:2152-9.
12. Duffy MJ, van Rossum LGM, van Turenhout ST, et al. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer 2011;128:3-11.
13. Wilschut JA, Habbema JD, van Leerdam ME, et al. Fecal occult blood testing when colonoscopy capacity is limited. J Natl Cancer Inst 2011;103:1741-51.
14. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
15. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
16. Halloran S, Launoy G, Zappa M. Faecal occult blood testing. In: Segnan N, Patnick J, von Karsa L; International Agency for Research on Cancer, eds. European Guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Publications Office of the European Union, 2010:103-44.
17. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occultblood screening for colorectal cancer. Lancet 1996;348:1472-7.